首页> 美国卫生研究院文献>Drug Delivery >Fabrication of a drug delivery system that enhances antifungal drug corneal penetration
【2h】

Fabrication of a drug delivery system that enhances antifungal drug corneal penetration

机译:制造增强抗真菌药物角膜渗透力的药物输送系统

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Fungal keratitis (FK) remains a severe eye disease, and effective therapies are limited by drug shortages and critical ocular barriers. Despite the high antifungal potency and broad spectrum of econazole, its strong irritant and insolubility in water hinder its ocular application. We designed and fabricated a new drug delivery system based on a polymeric vector for the ocular antifungal application of econazole. This novel system integrates the advantages of its constituent units and exhibits superior comprehensive performance. Using the new system, drug content was significantly increased more than 600 folds. The results of in vivo and in vitro experiments demonstrated that the econazole-loaded formulation exhibited significantly enhanced corneal penetration after a single topical ocular administration, excellent antifungal activity, and good tolerance in rabbits. Drug concentrations and ocular relative bioavailability in the cornea were 59- and 29-time greater than those in the control group, respectively. Following the topical administration of one eye drop (50 μL of 0.3% w/v econazole) in fungus-infected rabbits, a high concentration of antimycotic drugs in the cornea and aqueous humor was sustained and effective for 4 h. The mechanism of corneal penetration was also explored using dual fluorescent labeling. This novel drug delivery system is a promising therapeutic approach for oculomycosis and could serve as a candidate strategy for use with various hydrophobic drugs to overcome barriers in the treatment of many other ocular diseases.
机译:真菌性角膜炎(FK)仍然是一种严重的眼病,药物缺乏和严重的眼屏障会限制有效的治疗方法。尽管益康唑具有很高的抗真菌效力和广谱性,但其强烈的刺激性和在水中的不溶性阻碍了其眼部应用。我们设计和制造了一种新的基于高分子载体的药物递送系统,用于依康唑的眼部抗真菌应用。这种新颖的系统整合了其组成单元的优势,并展现出卓越的综合性能。使用新系统,药物含量显着增加了600倍以上。体内和体外实验的结果表明,单次局部眼部给药后,装载益康唑的制剂显示出明显增强的角膜渗透性,出色的抗真菌活性和对兔子的良好耐受性。角膜的药物浓度和眼部相对生物利用度分别比对照组高59倍和29倍。在真菌感染的兔子中局部滴眼液(50μL0.3%w / v益康唑50μL)后,角膜和房水中高浓度的抗真菌药物持续有效达4h。还使用双重荧光标记探索了角膜渗透的机制。这种新颖的药物递送系统是眼球菌病的一种有前途的治疗方法,并且可以用作与各种疏水性药物一起使用的候选策略,以克服许多其他眼科疾病的治疗障碍。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号